Insight
Investor Relations and Generative AI: The Risks and How to Manage Them
by Amy Walsh | December.07.2023
by Amy Walsh | December.07.2023
by Dr. Karsten Faulhaber and Franziska Gräfin Grote LL.M. | December.14.2023
by Aravind Swaminathan, Emily S. Tabatabai, Nicholas Farnsworth, Naomi Pen and Hayden Irwin | December.20.2023
by Minako Wakabayashi and Gohshun Kawamura | December.26.2023
In this Alert, we will discuss the trends related to local coexistence, as well as Round 2 offshore wind auction results.
by Jeff Zhang and Martha Wang | November.13.2023
by Amanda Lawrence, Aravind Swaminathan, Elizabeth McGinn, James Chou, Naomi Pen, Kathryn Ryan, Sherry-Maria Safchuk and Sasha Leonhardt | December.07.2023
by Shannon Yavorsky and Bianca Ponziani | October.19.2023
by David Rhinesmith, Aaron Brecher and Alison Epperson | October.26.2023
The Department of Justice (DOJ) recently unveiled a policy for voluntary disclosure of misconduct in mergers and acquisitions (M&A).
by John Coleman and Jeffrey Naimon | October.24.2023
After over a decade of discussion, the CFPB has issued a notice of proposed rulemaking to implement section 1033 of the Dodd-Frank Act.
July.17.2025
by Edward Dyson, Ed Lukins and Abigail Parkin | July.17.2025
FCA finalises rules replacing UK Prospectus Regulation from Jan 2026 to streamline fundraising and boost UK’s appeal as a listing venue.
July.21.2025
Life sciences VC slowed in Q2 2024, but deal sizes surged. Read on for trends + a roundtable on nontraditional funding and state-level programs.